Status:
RECRUITING
Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Rheumatic Heart Disease
Rheumatic Heart Disease in Children
Eligibility:
All Genders
5-16 years
Phase:
NA
Brief Summary
The overall objective is to evaluate the effectiveness of a school-centered primary and secondary prevention program on the prevalence of latent rheumatic heart disease among schoolchildren in Nepal, ...
Detailed Description
Three in four children worldwide grow up in regions of the world where patterns of acute rheumatic fever and rheumatic heart disease are endemic and where rheumatic heart disease accounts for \>300'00...
Eligibility Criteria
Inclusion Criteria:
- Age 5-16 years
- Attending Tulsi Secondary Boarding School in Tulsipur, Nepal.
Exclusion Criteria:
- Children / primary caregivers not providing informed consent to participate
- Children not attending Tulsi Secondary Boarding School in Tulsipur.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
2300 Patients enrolled
Trial Details
Trial ID
NCT05504928
Start Date
June 1 2022
End Date
December 1 2026
Last Update
August 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tulsi Secondary Boarding School
Tulsi̇̄pur, Nepal, 22412